The Clinical Advisory Board provides strategic guidance and support to the development of BLU-5937, BELLUS Health’s lead product candidate for chronic cough.

The members of the Clinical Advisory Board are:

Dr. Jaclyn Smith , MB, ChB, FRCP, PhD | Chair

Dr. Jaclyn Smith is a Professor of Respiratory Medicine at the University of Manchester in the United Kingdom and an Honorary Consultant at the University Hospital of South Manchester NHS Foundation Trust. She leads a multi-disciplinary research team whose focus is on understanding mechanisms underlying pathological cough and runs a regional clinical service for patients with refractory chronic cough. Dr. Smith is also the Director of the NIHR Manchester Clinical Research Facility. In collaboration with Mr. Kevin McGuinness (Clinical engineer), she has developed a novel method for automated cough detection.

Dr. Alan Goldsobel , MD

Dr. Alan Goldsobel is a practising allergist and immunologist, a Clinical Professor of Medicine at the University of California, San Francisco and an Adjunct Clinical Professor of Pediatrics at Stanford University Medical School. He is also a Fellow of the American Academy of Allergy, Asthma & Immunology and past president of the California Society of Allergy, Asthma & Immunology. Dr. Goldsobel is co-director of the Allergy and Asthma Clinical Research Center in San Jose, CA where he has served as principal investigator for clinical trials of many of the new therapeutic agents for chronic refractory cough. He has published numerous scientific articles and book chapters in allergy and asthma and his area of interest, cough.

Dr. James Hull , BSc, MBBS, FRCP, PhD, FACSM

Dr. James Hull is a consultant respiratory physician based at Royal Brompton Hospital. Recently he was awarded the fellowship status of the American College of Sports Medicine. He is also president of the Association for Respiratory Technology and Physiology (ARTP). His areas of expertise include chronic debilitating cough, persistent throat symptoms, unexplained shortness of breath, reasons for breathing problems during exercise. He is the clinical lead for the unexplained breathlessness service and the cough / upper airway / vocal cord dysfunction service at the Royal Brompton Hospital. He also has specialist expertise in helping athletes with respiratory symptoms and is currently working with the English Institute of Sport, as a respiratory expert.

Dr. Lorcan McGarvey , MD, FRCP

Dr. Lorcan McGarvey is a Consultant Respiratory Physician and Professor of Respiratory Medicine at Queen’s University of Belfast, Northern Ireland. His main programme of research has focused on the clinical and scientific aspects of acute and chronic cough. Dr. McGarvey has been a core contributor to the British Thoracic Society and European Respiratory Society cough guidelines and serves on the American College of Chest Physicians Cough Guidelines Expert Committee.

Dr. Alyn Morice , MD

Dr. Alyn Morice is a Professor of Respiratory Medicine, Head of Medicine, Hull York Medical School, University of Hull in the United Kingdom. He specialises in the diagnosis and treatment of cough and runs the Hull Cough Clinic, the first UK Cough Clinic which he established in 1989 and which has become the largest centre within Europe with an international pattern of referral. Professor Morice has led the European Respiratory Society and British Thoracic Society Taskforces on Cough. He also runs the Hull Respiratory Clinical Trials Unit specialising in the treatment of the airways diseases associated with cough.

Dr. Mandel Sher , MD

Dr. Mandel Sher is a community-based clinician of pediatric and adult allergy, University of South Florida’s Clinical Professor and former Interim Division Chief of Allergy and Immunology of University of South Florida located at Johns Hopkins/All Children's Hospital. With a unique sub-specialty in Refractory/ Recalcitrant/Idiopathic chronic cough, Dr. Sher established the Center for Cough in Florida in 2009, which combines existing evidence-based approaches with innovative therapeutic modalities to improve chronic cough patients’ clinical outcomes.

Share this

Sign up for email alerts

Email Address *
Enter the code shown above.